About NewAmsterdam Pharma Co. NV 
NewAmsterdam Pharma Co. NV
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 21 Schemes (15.11%)
Foreign Institutions
Held by 67 Foreign Institutions (21.84%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
19 Million
(Quarterly Results - Jun 2025)
Net Profit:
-17 Million
Pharmaceuticals & Biotechnology
USD 2,826 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.95
-17.87%
3.63






